Market Value: Oculis AG (OCS)

The daily price chart for Oaktree Specialty Lending (OCS) on the GURU.Markets platform demonstrates an asset with a 0.47 indicator, as the ophthalmology sector is not subject to market cycles or seasonal fluctuations. The business relies on a virtual management format, outsourcing drug testing to external contractors while maintaining strict quality oversight. Capitalization is based on the development of advanced therapies for retinal edema and inflammation.

OCS Oaktree Specialty Lending: Market Valuation in the range 04/28/2023 - 11/14/2026

Metric breakdowns and analytics for Oculis Pharma (OCS)

- current price and projected stock value:

Stock Price Oculis AG|OCS - Consensus Target

- company stock exchange capitalization indicators:

Market Value Oculis AG|OCS - Company Buyout Price

- book value of equity indicators:

Net Assets per Single Share Oculis|OCS - Net Asset Value|Market Capitalization to Book Value Ratio oculis.com|OCS - Aggregate Asset Value

- company liabilities and liquidity data:

- business earnings and investment ratios data:

OCS - Final Profit|Projected Future Earnings Oaktree Specialty Lending|OCS - Market Cap to Earnings|Projected Price to Earnings Oculis Pharma|OCS - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Oculis Pharma|OCS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Oculis|OCS - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months oculis.com|OCS - Earnings per share growth rate in current year|Earnings growth forecast for next year Oaktree Specialty Lending

- sales volume and revenue information:

OCS - Revenue and Sales Volume|Company Projected Revenue Oculis AG|OCS - P/S Multiple|Forward Price-to-Revenue Multiple Oculis Pharma

Summary company analysis:OCS (Oculis Holding AG)

Investors utilize market multiples to verify the issuer's financial stability and assess its investment potential. By analyzing the market capitalization of Oaktree Specialty Lending (OCS), calculated as the aggregate value of all securities, one can estimate the market value of Oaktree Specialty Lending (OCS) patents, as this indicator reflects venture capital confidence in future FDA decisions in the absence of revenue.

Competitors of Oaktree Specialty Lending (OCS)